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Intracellular transportthe Vpu protein from HIV-1 subtype C is more efﬁciently transported to the cell
surface than the well studied subtype B Vpu (Pacyniak et al., 2005) and that a SHIV expressing the subtype C
Vpu exhibited a decreased rate of CD4+ T cell loss following inoculation in macaques (Hill et al., 2008). In this
study, we examined the role of overlapping tyrosine-based (YXXΦ) and dileucine-based ([D/E]XXXL[L/I])
motifs in the membrane proximal region of the subtype C Vpu (EYRKLL) in Vpu intracellular transport, CD4
surface expression and virus release from the cell surface. We constructed three site-directed mutants of the
subtype C vpu and fused these genes to the gene for enhanced green ﬂuorescent protein (EGFP). The ﬁrst
mutation made altered the tyrosine (EARKLL; VpuSCEGFPY35A), the second altered the dileucine motif
(EYRKLG; VpuSCEGFPL39G), and the third contained both amino acid substitutions (EARKLG; Vpu-
SCEGFPYL35,39AG) in this region of the Vpu protein. The VpuSCEGFPY35A protein was transported to the
cell surface similar to the unmodiﬁed VpuSCEGFP1 while VpuSCEGFPL39G was expressed at the cell surface at
signiﬁcantly reduced levels. The VpuSCEGFPYL35,39AG was found to have an intermediate level of cell surface
expression. All three mutant Vpu proteins were analyzed for the ability to prevent cell surface expression of
CD4. We found that both single mutants did not signiﬁcantly effect CD4 surface expression while the double
mutant (VpuSCEGFPYL35,39AG) was signiﬁcantly less efﬁcient at preventing cell surface CD4 expression.
Chimeric simian human immunodeﬁciency viruses were constructed with these mutations in vpu
(SHIVSCVpuY35A, SHIVSCVpuL39G and SHIVSCVpuYL35,39AG). Our results indicate that SHIVSCVpuL39G replicated
much more efﬁciently and was much more cytopathic than SHIVSCVpu. In contrast, SHIVSCVpuY35A and
SHIVSCVpuYL35,39AG replicated less efﬁciently when compared to the parental SHIVSCVpu. Taken together, these
results show for the ﬁrst time that the membrane proximal tyrosine-based sorting motif in the cytoplasmic
domain of Vpu is essential for efﬁcient virus release. These results also indicate that the dileucine-based
sorting motif affects the intracellular trafﬁcking of subtype C Vpu proteins, virus replication, and release.
© 2008 Elsevier Inc. All rights reserved.IntroductionHuman immunodeﬁciency virus type 1 (HIV-1) and several strains
of simian immunodeﬁciency viruses (SIV) encode for a small protein
known as Vpu (Strebel et al., 1988; Cohen et al., 1988; Dazza et al.,
2005; Huet et al., 1990; Barlow et al., 2003; Courgnaud et al., 2002;
2003). Vpu is an integral membrane protein with highly conserved
and variable domains (Hout et al., 2004; Maldarelli et al., 1993;
McCormick-Davis et al., 2000a,b). The Vpu protein from a laboratory-
adapted subtype B HIV-1 has been extensively studied with respect to
its role in the virus life cycle and has identiﬁed two major functions in
replication. Vpu interacts with the CD4 receptor in the rough endo-.
l rights reserved.plasmic reticulum (RER) and shunts it to the proteasome for degra-
dation (Fujita et al., 1997; Schubert et al., 1998). Studies have shown
that the highly conserved hinge region of the cytoplasmic domain of
Vpu contains two casein kinase II sites that are required for the CD4
degradation (Paul and Jabbar, 1997; Schubert et al., 1994; Willey et al.,
1992). Other studies have shown that the predicted two α-helical
domains within the cytoplasmic domain and sequences within the
transmembrane (TM) domain of the subtype B Vpu are also required
for efﬁcient degradation of CD4 (Tiganos et al., 1998; Hout et al., 2006).
Additionally, Vpu also enhances virus release from infected cells,
which has been associated with the transmembrane domain and its
ion channel properties (Cordes et al., 2001; Ewart et al., 1996, 2002,
2004; Grice et al., 1997; Klimkait et al., 1990; Schubert et al., 1996a,b).
Examination of cells infected with HIV-1 viruses containing large
deletions within the vpu gene by electron microscopy revealed a
different pattern of virus maturation with many particles tethered
Fig. 1. Sequences of the proteins analyzed in this study. The underlined residues represent the tyrosine and dileucine motifs. The underlined residues in italics represent the amino
acid substitutions.
Fig. 2. Expression of EGFP, VpuSCEGFP1, VpuSCEGFPY35A, VpuSCEGFPL39G,or
VpuSCEGFPYL35,39AG in 293 cells. 293 cells were co-transfectedwith vectors expressing
VpuSCEGFP1, VpuSCEGFPY35A, VpuSCEGFPL39G, VpuSCEGFPYL35,39AG or EGFP. At 48 h,
cells expressing EGFP were identiﬁed and images collected using laser scanning confocal
microscopy as described in the Materials and methods section. Panel A. Phase image
merged with ﬂuorescence micrograph of a cell expressing VpuSCEGFP1. Panel B.
Fluorescence micrograph of a cell expressing VpuSCEGFP1. Panel C. Phase image merged
with ﬂuorescence micrograph of a cell expressing VpuSCEGFPY35A. Panel D. Fluorescence
micrograph of a cell expressing VpuSCEGFPY35A. Panel E. Phase image merged with
ﬂuorescence micrograph of a cell expressing VpuSCEGFPL39G. Panel F. Fluorescence
micrograph of a cell expressing VpuSCEGFPL39G. Panel G. Phase image merged with
ﬂuorescence micrograph of a cell expressing VpuSCEGFPYL35,39AG. Panel H. Fluorescence
micrograph of a cell expressing VpuSCEGFPYL35,39A.
59A. Ruiz et al. / Virology 378 (2008) 58–68together at the cell surface and within intracellular vesicles (Klimkait
et al., 1990).
Subtype C HIV-1 accounts for over 50% of the infections worldwide
(Takebe et al., 2004; Hemelaar et al., 2006). While the reasons for the
rapid spread of these viruses in the human population is currently
unknown, several studies have suggested differences between the
subtype C HIV-1 and viruses from the other subtypes of HIV-1 group
M. In one study, both non-syncytia-inducing (NSI)/R5 and syncytia
inducing (SI)/X4 subtype C HIV-1 isolates were found to be
signiﬁcantly less ﬁt in peripheral blood mononuclear cells (PBMC)
competition assays than all other group M isolates of the same
phenotype (Ball et al., 2003). More recently, in a study that evaluated
the replicative ﬁtness of representative strains from subtypes A, B, C, D
and CRF01_AE, the subtype C viruses were found to have less repli-
cative ﬁtness in PBMC compared to the other subtypes but were 100-
fold more ﬁt in these assays than HIV-2 or group O isolates (Arien
et al., 2005). In addition to replication in in vitro assays, the Vpu
proteins from subtype C HIV-1 isolates have biological properties and
structural features that differ from the well studied subtype B Vpu
protein. Previously, we showed that the subtype C Vpu protein was
efﬁciently transported to the cell surface while the subtype B Vpu
protein appears to be predominantly localized to intracellular com-
partments (Pacyniak et al., 2005). Recently, we also showed that the
subtype C Vpu was less efﬁcient at preventing surface expression of
CD4 than the subtype B protein and that replacement of the subtype B
vpu from a pathogenic molecular clone of SHIV (SHIVKU-1bMC33)with
the vpu gene from a subtype C clinical isolate resulted in a decreased
rate of CD4+ T cell loss following inoculation into macaques (Hill et al.,
2008). In this study, we examined the role of the unique overlapping
tyrosine (YXXΦ; withΦ being an amino acid with a large hydrophobic
side chain) and dileucine ([D/E]XXXL[L/I]) motifs on the intracellular
trafﬁcking of the subtype C Vpu, CD4 surface expression and viral
release from infected cells. Our results show for the ﬁrst time that a
dileucine-based sorting signal can affect trafﬁcking of the Vpu protein,
the extent of cytopathology, the enhanced release function of Vpu and
the efﬁciency of cell surface CD4 surface expression.
Results
Transport to the cell surface is reduced in subtype C Vpu fusion protein
with mutations in the dileucine motif
The sequences of the Vpu mutants analyzed in this study are shown
in Fig. 1. We ﬁrst analyzed the ability of the Vpu mutants to be tran-
sported to the cell surface using two different assays. 293 cells were
transfectedwith vectors expressingeitherVpuSCEGFP1, VpuSCEGFPY35A,
VpuSCEGFPL39G, or VpuSCEGFPYL35,39AG. At 48 h post-transfection,
cells were analyzed by laser scanning confocal microscopy. As shown in
Figs. 2A–D, the VpuSCEGFP1 and VpuSCEGFPY35A localized at the cell
plasma membrane. In contrast, the VpuSCEGFPL39G and Vpu-
SCEGFPYL35,39AG clearly had reduced expression at the cell surface(Figs. 2E–H). Of these two constructs, the VpuSCEGFPL39A consistently
had the lowest surface expression. As the results in Fig. 2 suggested that
VpuSCEGFPL39G and VpuSCEGFPYL35,39AG were expressed at reduced
60 A. Ruiz et al. / Virology 378 (2008) 58–68levels, we analyzed which compartment these proteins were predomi-
nantly localized. 293 cells were cotransfected with vectors expressing
VpuSCEGFP1,VpuSCEGFPY35A,VpuSCEGFPL39G,orVpuSCEGFPYL35,39AG
and DsRed2-Golgi. As shown in Fig. 3, VpuSCEGFPY35A (Fig. 3E–H) was
predominately expressed at the cell surface while the majority of the
VpuSCEGFPL39G (Figs. 3I–L) and VpuSCEGFPYL35,39AG (Figs. 3M–P)
colocalizedwith the DsRed2-Golgimarker.We next analyzed the ratio of
the ﬂuorescent signal at the cell surface to that within the Golgi complex
as described in theMaterials andmethods section. As shown in Fig. 4, we
found that the ratio of surface to Golgi ﬂuorescent signal was 0.29 for
VpuSCEGFP1 and 0.32 for VpuSCEGFPY35A. In contrast, VpuSCEGFPL39G
andVpuSCEGFPYL35,39AGhad ratios of 0.06and0.18, respectively,which
were consistent with what was observed in Fig. 2. To conﬁrm these
ﬁndings, transfected cells were surface biotinylated followed by im-
munoprecipitation with an anti-EGFP antibody. As shown in Fig. 5,
biotinylated VpuSCEGFP1 (100%) and VpuSCEGFPY35A (110–120%) wereFig. 3. Expression of EGFP, VpuSCEGFP1, VpuSCEGFPY35A, VpuSCEGFPL39G or VpuSCEGFPY
expressing VpuSCEGFP1, VpuSCEGFPY35A, VpuSCEGFPL39G, VpuSCEGFPYL35,39AG or EGFP a
using laser scanning confocal microscopy as described in the Materials and methods section.
contrast image of a cell expressing VpuSCEGFP1 and DsRed2-Golgi. Panel B. Fluorescence m
expressing DsRed2-Golgi. Panel D. Merge of panels B and C. Panels E–H. 293 cells co-trans
expressing VpuSCEGFPY35A and DsRed2-Golgi. Panel F. Fluorescence micrograph of a cell exp
Golgi. Panel H. Merge of panels F and G. Panels I–L. 293 cells co-transfected with VpuSCEGFPL3
and DsRed2-Golgi. Panel J. Fluorescencemicrograph of a cell expressing VpuSCEGFPL39G. Pan
J and K. Panels M–P. 293 cells co-transfected with VpuSCEGFPYL35,39AG and DsRed2-Golgi.
Golgi. Panel N. Fluorescence micrograph of a cell expressing VpuSCEGFPYL35,39AG. Panel O.
and O.easily detected at the cell surface. In contrast, decreased levels of
VpuSCEGFPL39G (30%) and VpuSCEGFPYL35,39AG (40%) were found at
the cell surface. Together, these results indicate that VpuSCEGFPY35Ahad
slightly higher (but not statistically signiﬁcant) levels at the cell surface,
VpuSCEGFPYL35,39AG had an intermediate level of expression and
VpuSCEGFPL39G had the lowest level of surface expression.
The reduced level of expression of VpuSCEGFPL39G and
VpuSCEGFPYL35,39AG was not due to enhanced turnover of the protein
One possible explanation for the reduced expression of
VpuSCEGFPL39G and VpuSCEGFPYL35,39AG at the cell surface could
be due to the stability of the viral proteins. Pulse-chase experiments
were performed to examine the rate of turnover of VpuSCEGFP1 and the
threemutant Vpu proteins. As shown in Figs. 6A–D,VpuSCEGFP1 and the
three mutant Vpu proteins had 62–69% of the protein remaining at theL35,39AG and DsRed2-Golgi in 293 cells. 293 cells were co-transfected with vectors
nd DsRed2-Golgi. At 48 h, cells expressing EGFP were identiﬁed and images collected
Panels A–D. 293 cells co-transfected with VpuSCEGFP1 and DsRed2-Golgi. Panel A. Phase
icrograph of a cell expressing VpuSCEGFP1. Panel C. Fluorescence micrograph of a cell
fected with VpuSCEGFPY35A and DsRed2-Golgi. Panel E. Phase contrast image of a cell
ressing VpuSCEGFPY35A. Panel G. Fluorescence micrograph of a cell expressing DsRed2-
9G and DsRed2-Golgi. Panel I. Phase contrast image of a cell expressing VpuSCEGFPL39G
el K. Fluorescencemicrograph of a cell expressing DsRed2-Golgi. Panel L. Merge of panels
Panel M. Phase contrast image of a cell expressing VpuSCEGFPYL35,39AG and DsRed2-
Fluorescence micrograph of a cell expressing DsRed2-Golgi. Panel P. Merge of panels N
Fig. 4. Themembrane to Golgi ratios for VpuSCEGFP1, VpuSCEGFPY35A, VpuSCEGFPL39G,
and VpuSCEGFPYL35,39AG. Z-stacks were compiled for 42 cells expressing each of the
above proteins at 48 h post-transfection. Using the Zeiss software package, the
ﬂuorescence intensity of the cell plasma membrane and Golgi complex were analyzed
and the ratio computed. Shown are the mean ratios of membrane to Golgi ﬂuorescence
for each of the four constructs. The control for the studies was VpuEGFP, which is
primarily localized in the Golgi complex with little on the cell surface.
61A. Ruiz et al. / Virology 378 (2008) 58–686 h chase period. These results indicate that protein stabilitywas not the
reason for the observed results in Figs. 2–5.
Cell surface expression of CD4 by the tyrosine and dileucine mutants
We examined the ability of VpuSCEGFP1 and the three Vpumutants
to down-regulate cell surface CD4 expression. HeLa CD4+ cells were
transfected with vectors expressing VpuSCEGFP1 and the three Vpu
mutants. At 48 h, cells were removed from the plates, stained for
surface CD4 and analyzed by ﬂow cytometry. The results in Fig. 7 show
that CD4 surface expression in cells expressing either VpuSCEGFPL39G
or VpuSCEGFPY35Awas not statistically signiﬁcant when compared to
VpuSCEGFP1. However, cells transfected with VpuSCEGFPYL35,39AG
had a statistically signiﬁcant increase in CD4 cell surface expres-
sion when compared to VpuSCEGFP1 (pb0.05). These results indicate
that removal of both the tyrosine and dileucine signals effected CD4
down-regulation.
SHIVs expressing Vpu proteins with mutations in the dileucine motifs
replicate faster than those with mutations in tyrosine motif
We constructed simian human immunodeﬁciency viruses that
expressed a Vpu protein with either the Y35A (SHIVSCVpuY35A), theFig. 5. Detection of subtype C Vpu mutants by surface biotinylation. 293 cells were
transfected with vectors expressing VpuSCEGFP1, VpuSCEGFPY35A, VpuSCEGFPL39G,
VpuSCEGFPYL35,39AG, or EGFP. At 48 h, cells were radiolabeled and surface biotinylated
as described in the Materials and methods section. EGFP containing proteins were
immunoprecipitated using an anti-EGFP serum and run on SDS-PAGE. The proteins
were transferred to membranes and reacted with a substrate to visualize the
biotinylated proteins. Lane 1. Cells transfected with EGFP. Lane 2. Cells transfected
with VpuSCEGFP1. Lane 3. Cells transfected with VpuSCEGFPY35A. Lane 4. Cells
transfected with VpuSCEGFPL39G. Lane 5. Cells transfected with VpuSCEGFPYL35,39AG.
Lane 6. Untransfected cells, control.L39G (SHIVSCVpuL39G) or the YL35,39AG (SHIVSCVpuYL35,39AG) amino
acid substitutions. The replication of these viruses was assessed using
p27 growth curves and compared to parental SHIVSCVpu. The results of
these assays are shown in Fig. 8 and indicate that SHIVSCVpuL39G
released p27 into the culture medium faster and was 5.6-fold higher
than parental SHIVSCVpu at day 7 post-inoculation. Additionally, we
observed that cultures inoculated with SHIVSCVpuL39G developed
syncytial cytopathology at a faster rate (and larger) compared to the
other three viruses (data not shown). In contrast, the SHIVSCVpuY35A
and SHIVSCVpuYL35,39AG released p27 into the culture medium at a
slower rate and at day 7were 10.3 and 7.4-fold less, respectively, when
compared to the parental SHIVSCVpu. It should be noted that in four
attempts to prepare stocks of SHIVSCVpuY35A, three of the stocks
selected for a highly cytopathic variant. Sequence analysis of the vpu
gene ampliﬁed from cells isolated from infected cultures revealed a
premature stop codon in vpu at amino acid position 28 (data not
shown). Since we have never encountered this problem in construc-
tion of other SHIVs, it suggests that the lack of a tyrosine residue at this
position is being compensated for by truncation of the protein. Taken
together, these results indicate that the tyrosine residue appeared to
be required for efﬁcient virus particle release and that removal of the
dileucine motif resulted in a virus that replicated much more
efﬁciently.Fig. 6. Pulse-chase analyses of the Vpu fusion proteins. To determine if the amino acid
substitutions resulted in altered turnover of the Vpu fusion proteins, 293 cells were
transfected with vectors expressing either VpuSCEGFP1, VpuSCEGFPY35A, Vpu-
SCEGFPL39G, or VpuSCEGFPYL35,39AG. At 48 h post-transfection, the medium was
removed and cells were incubated in methionine/cysteine-free medium for 2 h. The
cells were then radiolabeled for 30 min with 1 mCi of 35S-Translabel (methionine and
cysteine, ICN Biomedical, Costa Mesa, CA) and the radiolabel chased for various periods
of time (0–6 h) in DMEM containing 100× unlabeled methionine/cysteine. Vpu fusion
proteins were immunoprecipitated using an anti-EGFP serum as described in the
Materials and methods. Non-transfected 293 cells, radiolabeled and chased for 6 h
served as a negative control (lane C). All immune precipitates were collected on protein
A Sepharose, the beads washed three times with RIPA buffer, and the samples
resuspended in sample reducing buffer. Samples were boiled and the SHIV speciﬁc
proteins analyzed by SDS-PAGE (10% gel). Proteins were then visualized by standard
autoradiographic techniques. Panel A. Results of pulse-chase analysis of viral proteins
immunoprecipitated from VpuSCEGFP1 transfected cells. Panel B. Results of pulse-chase
analysis of viral proteins immunoprecipitated from VpuSCEGFPY35A transfected cells.
Panel C. Results of pulse-chase analysis of viral proteins immunoprecipitated from
VpuSCEGFPL39G transfected cells. Panel D. Results of pulse-chase analysis of viral
proteins immunoprecipitated from VpuSCEGFPYL35,39AG transfected cells.
Fig. 7. Substitution of tyrosine and leucine residues at positions 35 and 39 results in a protein that is less efﬁcient at down-regulating cell surface CD4 expression. HeLa CD4+ cells were
transfectedwith plasmids expressing EGFP, VpuSCEGFP1, VpuSCEGFPY35A, VpuSCEGFPL39G, or VpuSCEGFPYL35,39AG. At 48 h, live cells were immunostained for CD4. Cells expressing
EGFP or EGFP fusion proteins were assessed for CD4 surface expression using ﬂow cytometry. CD4 expression in cells expressing the various Vpu proteins was normalized to CD4
expression in EGFP expressing cells. p-values above bars are those Vpu proteins that were less efﬁcient at CD4 down-regulation and reached signiﬁcance.
Fig. 8. Growth curves of SHIVSCVpu, SHIVSCVpuY35A, SHIVSCVpuL39G and SHIVSCVpuYL35,39AG
in C8166 cells. Cultures of C8166 cells were inoculated with either SHIVSCVpu (●),
SHIVSCVpuY35A (■), SHIVSCVpuL39G (▲) and SHIVSCVpuYL35,39AG (♦) as described in the text.
Aliquots of the culture medium were assayed for the presence of p27 antigen. The
growth curves were performed in triplicate and the mean of the three experiments
plotted.
62 A. Ruiz et al. / Virology 378 (2008) 58–68SHIVSCVpuL39G processes Gag and Env precursors faster than
SHIVSCVpuY35A and SHIVSCVpuYL35,39AG
Pulse-chase experiments were used to analyze the processing of
viral Gag and Env proteins. C8166 cells were inoculated with
either SHIVSCVpu, SHIVSCVpuY35A SHIVSCVpuL39G, or SHIVSCVpuYL35,39AG
for 5 days at which time pulse-chase analyses were performed.
The results of the pulse-chase analysis for SHIVSCVpu are shown in
Fig. 9A (Hill et al., 2008). The results of the pulse-chase analyses
for SHIVSCVpuL39G (Fig. 9B) indicate that Env and Gag protein
precursors were processed similar to SHIVSCVpu but faster than
either SHIVSCVpuY35A (Fig. 9C) or SHIVSCVpuYL35,39AG (Fig. 9D). This
was also reﬂected in the release of the viral proteins into the
culture medium (data not shown). Together, these data correlated
well with the p27 growth curves.
SHIVs with the L39G amino acid substitution exhibit more particles on
the cell surface
We examined the maturation of SHIVSCVpu, SHIVSCVpuY35A,
SHIVSCVpuL39G and SHIVSCVpuYL35,39AG by electron microscopy to
determine if these amino acid substitutions altered the pattern of
virus maturation. As shown in Fig. 10A, the SHIVSCVpu was found to
mature at the cell surface as we recently reported (Hill et al., 2008).
SHIVSCVpuY35A, SHIVSCVpuL39G, and SHIVSCVpuYL35,39AG were also
found to mature predominantly at the cell surface (Figs. 10B–D)
although viral particles were occasionally observed within vesicles
of SHIVSCVpuL39G infected cells (Fig. 10E). The salient feature of the
electron microscopy studies was the number of viral particles
associated per infected cell. We determined the mean number of
particles per cell (50 cells counted) at 5 days post-inoculation. As
shown in Fig. 11A, the mean number of virus particles from 50
SHIVSCVpu-infected C8166 cells was approximately 16. The number of
particles per cell for SHIVSCVpuY35A and SHIVSCVpuYL35,39AG-infected
cells was approximately 3 and 8, respectively (Figs. 11B–C).
Contrasting with these results, SHIVSCVpuL39G had a mean of
approximately 75 particles per cell or approximately 5 times as
many particles as parental SHIVSCVpu (Fig. 11D). The differences in
the mean number of particles per cell between SHIVSCVpu andSHIVSCVpuL39G, SHIVSCVpu and SHIVSCVpuYL35,39AG, and SHIVSCVpu and
SHIVSCVpuY35Awere found to be very signiﬁcant (pb0.001). Analysis of
the distribution of the number of particles per cell also showed a clear
difference between SHIVSCVpuL39G and the other three viruses. For
SHIVSCVpu, the number of particles per cell was generally less than 30
(Fig. 11A) while for SHIVSCVpuYL35,39AG and SHIVSCVpuY35A the number
of particles per cell was less than 20 and 10, respectively (Figs.11B–C).
These results were in contrast with those for SHIVSCVpuL39G, which
showed a more even distribution in the number of particles per cell
(Fig. 11D). Combined with the p27 growth curves, while there were
increased numbers of virus particles on the surface, the virus
replicated with increased kinetics and released more p27 into the
culture medium.
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The subtype C Vpu proteins have canonical tyrosine (YXXΦ) and
dileucine ([D/E]XXXL[L/I]) motifs that could be involved in the
targeting of this protein to different intracellular compartments. The
targeting of proteins containing these motifs is generally mediated
through interactions with various adaptor protein complexes (AP-1,
AP-2, AP-3, AP-4). The YXXΦ signals have been shown to be involved in
endocytosis of membrane proteins from the cell plasma membrane as
well as targeting of membrane proteins to lysosomes and lysosome-
related vesicles. The YXXΦ motifs that are involved in endocytic
functions generally have a glycine residue at the Y+1 position and are
located 10–40 amino acids from the transmembrane of the protein.
Those YXXΦmotifs that are involved in lysosomal targeting generally
have an acidic residue at the Y+1 position and are generally located 6–
9 residues from the transmembrane domain (Bonifacino and Traub,
2003). Tyrosine signals generally interact with the μ subunit of adaptorFig. 9. Pulse-chase analyses revealed that SHIVSCVpuY35A, SHIVSCVpuL39G and SHIVSCVpuYL35,39A
releasedwith reduced efﬁciency in SHIVSCVpu-inoculated cultures, C8166 cells were inoculate
At 7 days post-infection, the mediumwas removed and infected cells were incubated in met
1 mCi of 35S-Translabel (methionine and cysteine, ICN Biomedical, Costa Mesa, CA) and the ra
methionine/cysteine. SHIV proteins were immunoprecipitated from cell lysates using plasm
the Materials and methods. Uninfected C8166 cells, radiolabeled and chased for 6 h serve
Sepharose, the beads washed three times with RIPA buffer, and the samples resuspended in s
SDS-PAGE (10% gel). Proteins were then visualized by standard autoradiographic technique
SHIVSCVpu SHIVSCVpu-infected cell lysates. Panel B. Results of pulse-chase analysis of viral pr
pulse-chase analysis of viral proteins immunoprecipitated from SHIVSCVpuY35A infected cell ly
SHIVSCVpuYL35,39AG infected cell lysates.protein complexes. The best-studied interactions with the AP com-
plexes have been predominantly with μ2, although the μ1, μ3, and μ4
subunits can interactwith thesemotifs. The μ3A and μ3B subunits have
a preference for binding to tyrosine signals with an acidic amino acid
before and/or after the tyrosine residue. The most characteristic
feature of the μ4 subunit binding is the presence of aromatic amino
acids near the tyrosine residue. With dileucine motifs, the ﬁrst leucine
is generally invariant and replacement of the ﬁrst leucine with an
isoleucine reduces the potency of the signal. However, the second
leucine can be replaced with an isoleucine and in some cases a
methionine residue with an acidic amino acid at the +4 and/or +5
position and retain signal function. Dileucine motifs also interact with
adaptor protein complexes AP-1, AP-2, andAP-3 (Bonifacino and Traub,
2003), but they appear to interact with a hemi-complex formed by the
small subunit and the large speciﬁc subunit (Janvier et al., 2003).
Similar to the tyrosine motifs, the proximity to the transmembrane
domain appears to affect whether it is involved in endocytosis orG have altered processing of viral proteins. To determine if viral structural proteins were
dwith 104 TCID50 of either SHIVSCVpu, SHIVSCVpuY35A, SHIVSCVpuL39G or SHIVSCVpuYL35,39AG.
hionine/cysteine-free medium for 2 h. The cells were then radiolabeled for 30 min with
diolabel chased for various periods of time (0–6 h) in DMEM containing 100× unlabeled
a pooled from several pig-tailed monkeys infected previously with SHIV as described in
d as a negative control (lane C). All immune precipitates were collected on protein A
ample reducing buffer. Samples were boiled and the SHIV speciﬁc proteins analyzed by
s. Panel A. Results of pulse-chase analysis of viral proteins immunoprecipitated from
oteins immunoprecipitated from SHIVSCVpuL39G infected cell lysates. Panel C. Results of
sates. Panel D. Results of pulse-chase analysis of viral proteins immunoprecipitated from
Fig. 10. Electron microscopic examination of C8166 cells inoculated with SHIVSCVpu, SHIVSCVpuY35A, SHIVSCVpuL39G, and SHIVSCVpuYL35,39AG. C8166 cells were inoculated with each virus
for 7 days. Cells were washed three times with PBS and processed for electron microscopy as described in the Materials and methods section. Panel A. C8166 cells inoculated with
parental SHIVSCVpu. Panel B. C8166 cells inoculated with SHIVSCVpuY35A. Panels C and D. C8166 cells inoculated with SHIVSCVpuYL35,39AG. Panels E and F. C8166 cells inoculated with
SHIVSCVpuL39G.
64 A. Ruiz et al. / Virology 378 (2008) 58–68lysosomal targeting. As the overlapping tyrosine and dileucine motifs
of Vpu are membrane proximal, it suggests that they may be involved
in lysosomal targeting.
In this study we analyzed the role of overlapping tyrosine and
dileucine signals within the cytoplasmic domain of the subtype C Vpu
in intracellular targeting. The two other membrane proteins of HIV-1,
Env and Nef, use tyrosine and dileucine motifs for either trafﬁcking
within the cell and/or removal of cellular proteins from the cell surface
(Boge et al., 1998; Bresnahan et al., 1998; Byland et al., 2007;
Chaudhuri et al., 2007; Coleman et al., 2005; Craig et al., 1998; Day
et al., 2006; Greenberg et al., 1998; Lodge et al., 1997; Noviello et al.,
2007; Roeth et al., 2004; Schwartz et al., 1996). Our ﬁndings indicate
that the tyrosine motif within Vpu may have a role in enhanced virus
release. The ﬁnding that the tyrosine-based motif was important to
virus release is not entirely surprising as this motif is conserved in
virtually all of the Vpu sequences from the different HIV-1 subtypes in
the Los Alamos National Laboratory (LANL)-HIV-1 group M database.
Recently, BST-2/CD317 or “tetherin” was identiﬁed as a target for Vpu
(Neil et al., 2008; Van Damme et al., 2008). This protein was shown to
prevent BST-2/CD317 expression at the cell surface and that expres-
sion of this protein correlated with the requirement of Vpu for
enhanced virion release. However, a direct interaction of Vpu and BST-2/CD317 has yet to be demonstrated. As changing the tyrosine residue
at position 35 to an alanine in the subtype C Vpu protein resulted in a
virus, SHIVSCVpuY35A, that replicated very poorly in C8166 cells, it raises
the question, “Is the membrane proximal tyrosine motif important in
the Vpu interactions with BST-2?” If Vpu interacts directly with BST-2/
CD317, it may be possible that Vpu could either prevent the transport
of this protein to the cell surface and/or sequester this protein to the
intracellular compartment(s) such that it will not effect virus release.
Membrane proximal dileucinemotifs are found in a high percentage
of subtype C Vpu sequences in the LANL-HIV-1 database, with
approximately 80% of the sequences having a dileucine, leucine–
isoleucine or leucine–valine motif at the membrane proximal location.
In contrast, of the 271 subtype B Vpu sequences in the LANL-HIV
database, the majority (~95%) of the sequences have an isoleucine in
place of the primary leucine (EYRKIL) with only 5.2% of the sequences
having dileucine, leucine–isoleucine or leucine–valine motif. Similar to
YXXΦ signals, [D/E]XXXL[L/I] signals inmammalianmembrane proteins
canmediate both rapid internalization aswell as targeting to endosomal
and lysosomal compartments. This indicates that they can be recognized
at the plasma membrane and the intracellular compartments. In
addition, [D/E]XXXL[L/I] signals have been implicated in trafﬁcking of
membrane proteins to basolateral membranes in polarized epithelial
Fig. 11. Enumeration of the number of viral particles associated with the infected C8166 cells following inoculation with SHIVSCVpu (Panel A), SHIVSCVpuY35A (Panel B),
SHIVSCVpuYL35,39AG (Panel C) and SHIVSCVpuL39G (Panel D). Cells were inoculated with equivalent doses of infectious virus and at 5 days processed for electron microscopy as described
in the Materials and methods section. The number of viral particles associated with 50 cells per sample were counted and mean values calculated.
65A. Ruiz et al. / Virology 378 (2008) 58–68cells (Hunziker et al., 1994; Ickling et al., 2007; Lodge et al., 1994; Matter
et al., 1994; Miranda et al., 2001). Our results indicate that the dileucine
sorting signal within the subtype C Vpu protein was important for
efﬁcient transport and expression at the cell surface. Substitution of the
second leucinewith a glycine resulted in a protein (VpuSCEGFPL39G) that
was transported to thecell surface less efﬁcientlywith themajority being
retained within the Golgi complex. The virus constructed with this
mutation, SHIVSCVpuL39G, was found to replicate much better than the
SHIV with the unmodiﬁed subtype C Vpu protein (SHIVSCVpu). We also
found that SHIVSCVpuL39G replicates as well as the SHIV expressing the
subtype B Vpu protein (SHIVKU-1bMC33). While speculative at this
juncture, one explanation for these observations is that the presence of
the [D/E]XXXL[L/I] motifmay interferewith the function of the tyrosine-
based signal. Possibly, the subtype C Vpu protein does not interact with
AP complexes for sorting of the protein to intracellular compartments
resulting in the transport of the protein to the cell surface. By removing
the dileucine sequence, the protein may be allowed to interact with
cellular components that target the protein to an intracellular
compartment.
Our results raise the important question, “Whywould the subtype C
viruses select for a dileucine signal thatwould hinder virus replication?”It has been hypothesized that subtype C HIV-1may be evolving to a less
virulent form (Arien et al., 2007). Data to support this hypothesis include
that the subtype C viruseswere found to be less ﬁt in PBMC competition
assays (Ball et al., 2003; Arien et al., 2005). Additional support comes
fromour recent studyusing SHIVSCVpuwherewe exchanged the subtype
B vpuwith one from a clinical subtype C isolate (Hill et al., 2008). In this
study,we showed that inoculationof pig-tailedmacaqueswith this virus
resulted in a slower rate of CD4+ T cell loss compared to our highly
pathogenic subtype B SHIVKU-1bMC33. It will be of interest to determine if
inoculation ofmacaqueswith the SHIVSCVpuL39G causes amore rapid loss
of CD4+ T cells.
Materials and methods
Cells, viruses and vectors
The 293 cell line was maintained in Dulbecco's minimal essential
medium supplemented with 10% fetal bovine serum, gentamicin
(5 mg per ml) and penicillin/streptomycin (100 U per ml and 100 μg
per ml). A C8166 cell line was used as the indicator cells to measure
infectivity and cytopathicity of the viruses used in this study. C8166
66 A. Ruiz et al. / Virology 378 (2008) 58–68cells were maintained in RPMI-1640, supplemented with 10 mM
Hepes buffer at pH 7.3, 2 mM glutamine, 5 μg per ml gentamicin and
10% fetal bovine serum (R10FBS). HeLa CD4+ cells were obtained from
the NIH AIDS Research and Reference Reagents Program and were
maintained in Dulbecco's minimal essential medium supplemented
with 10% fetal bovine serum, 5 μg per ml gentamicin, and 1 mg per ml
G-418. The derivation and pathogenicity of SHIVKU-1bMC33 has been
described (McCormick-Davis et al., 2000b; Stephens et al., 2002; Singh
et al., 2003). A derivative of this virus, known as SHIVSCVpu, is identical
to SHIVKU-1bMC33 except that this virus expresses the subtype C Vpu
protein (Hill et al., 2008). Vectors expressing the subtype B
(pcvpuegfp) and C Vpu (pcvpuscegfp1) proteins fused to enhanced
green ﬂuorescent protein (eGFP) have been previously described
(Singh et al., 2003; Gomez et al., 2005; Pacyniak et al., 2005). The
vectors expressing the DsRed2-Golgi were obtained from Clontech.
Construction of vectors expressing the subtype C mutants
For the construction of the subtype C Vpu mutants, site-directed
mutagenesis was performed on the parental plasmid, pcvpuSCegfp1.
Site directed mutagenesis was performed using this plasmid in the
Quick Change Mutagenesis kit (Stratagene) and oligonucleotides (only
sense strand shown) 5′-GCATATATAGAAGCTAGAAAATTGTTAAGACAG-
3′ (to change the tyrosine residue at position 35 to an alanine), 5′-
GAATATAGAAAATTGGGAAGACAGAAAAAGATAGAC-3′ (to change the
leucine at position 39 to a glycine), and 5′-GAAGCTAGAAAATTGG-
GAAGACAGAAAAAGATAGAC-3′ (to change the tyrosine and leucine at
positions 35 and 39) according to the manufacturerTs instructions.
With all mutants, the entire insert was sequenced (both vpu and egfp
genes) to ensure the validity of the mutations introduced and that no
additional changes were introduced during the mutagenesis process.
Transfections and laser scanning confocal ﬂuorescence microscopy
analysis
VpuEGFP and other plasmidswere transfected in human 293 cells to
assess their subcellular localization using a cationic polymer (poly-
ethylenimine) transfection reagent (ExGen™ 500,MBI Fermentas) using
the manufacturer's protocol. Brieﬂy, 1–3×105 cells were seeded onto
coverslips in each well of a 6 well tissue culture plate 24 h prior to
transfection. Transfectionwas carried out on cultures that were 50–60%
conﬂuent using 4.75 μg of plasmid DNA and 15.5 μl of ExGen™500
corresponding to6 equivalents. EachplasmidDNAsamplewasdiluted in
300 μl of 150 mM sodium chloride solution. Samples were vortexed
gently and immediately centrifuged at low revolution for a few seconds.
Polyethylenimine was then added to the plasmid DNA solution, mixed
with a vortex and allowed to stand at room temperature for 10min. The
293 cells werewashedwith serum freemedia twice and 3.0ml of serum
free DMEM was added. Polyethylenimine/DNA mixture was added to
the cells and the plate swirled by slow hand rotation for a couple of
seconds. Culture plates were centrifuged at 280 ×g for 5 min and
incubated at 37 °C for 30 min. The medium from transfected cultures
was replaced with fresh complete growth media and cells were
incubated at 37 °C in 5% CO2 atmosphere.
At 48 h post-transfection, cells were rinsed brieﬂy in phosphate
buffered saline (PBS, pH 7.2) at room temperature. The cells were ﬁxed in
freshly prepared, ice-cold 1% paraformaldehyde in 0.13 M sodium
phosphate at pH 7.2 for 2 min. The ﬁxative was removed and the cells
brieﬂy rinsed in phosphate buffered saline. The saline was removed, and
one drop of mounting media (Slowfade Antifade, Molecular Probes) was
placed on a slide and the coverslip mounted. The cells were imagedwith
a Zeiss LSM 510 confocal microscope in the upright conﬁguration. The
objective used was a 63×1.4 n.a. Plan-Apochromat. Images were
captured at 12 bit resolution with a pixel array of 2048×2048 and a
zoom of 2.0×. The signal was averaged 4 times per line. The EGFP was
excited with light at 488 nm (laser intensity 75% for all images), and theemitted light was collected through a 505 nm long pass ﬁlter. The
ampliﬁeroffset andgainwere identical for all images. Thepinholewas set
to 96 μmwhich at this wavelength represents one airey unit. The optical
section had a width of 0.7 μm. Simultaneous to the acquisition of the
confocal signal from the EGFP, a non-confocal transmitted light image
was obtained to provide a reference point for the EGFP signal. Individual
confocal slices were overlaid onto the greyscale transmitted light image.
To conﬁrm the presence of the Vpu fusion protein at different
subcellular compartments, co-transfection studies were performed
using vectors expressing aGolgimarker fused to theﬂuorescent protein
DsRed2 (DsRed2-Golgi). 293 cells were co-transfected with vectors
expressing the various Vpu fusion proteins and a vector expressing the
subcellular marker. At 48 h post-transfection, cells were processed for
confocalmicroscopy as described above, and cells identiﬁed expressing
both proteins. Fluorescent digital images were obtained using a Zeiss
LSM510 confocal microscope equipped with Argon and HeNe2 lasers
(25 mW) for the excitation (488 nm, 50% laser power) and detection
(band pass 505–530 nm ﬁlter; BP505–530) of EGFP and for excitation
(558 nm, 100% laser power) and detection (band pass 583 nm ﬁlter;
LP560) of DsRed2. Images were acquired in Multitrack channel mode
(sequential excitation/emission) with LSM510 (v 3.2) software and a
Plan-Apochromat 63/1.4 Oil DIC objective with frame size of
2048×2048 pixels. Detector gain was set initially to cover the full
range of all the samples and background corrected by setting the
ampliﬁer gain, and all images were then collected under the same
photomultiplier detector conditions and pinhole diameter.
In order to compare the level of expression of theVpu fusionproteins
on the cell surface, the ratio of the expression on the cell surface versus
the Golgi complex was determined. For this, 293 cells were plated,
transfected with various fusion proteins, ﬁxed and mounted as
described above. Using the Z function within LSM510, the depth of the
top and bottomof the individuallyﬂuorescent cellswere found. A 0.5 μm
slice picturewas taken at a depthequidistant fromthe top andbottomof
the cell. All pictureswere takenwith the same pinhole and detector gain
for uniformity. Aproﬁle linewasdrawn fromoutside the cell through the
Golgi, and reference points chosen in the cell surface and Golgi. The
ﬂuorescence intensity from those two reference points was recorded
and a ratio of membrane to Golgi intensity was calculated. Ratios were
taken from at least 42 separate cells, averaged and the standard
deviation calculated. Student's t-testwasused todetermine signiﬁcance,
with pb0.05 considered signiﬁcant.
Construction of viruses with the tyrosine and dileucine mutations
For the construction of a subtype C SHIV containing tyrosine and
dileucine mutations, we used plasmid pUCvpuSC, which contains the
tat and rev of HIV-1 (HXB2), the subtype C vpu and the 5′ end of the env
gene. To introduce the tyrosine and dileucine mutations, we used this
plasmid and the same oligonucleotides and procedures used for site-
directed mutagenesis as described above for the construction of the
Vpu/EGFP fusion proteins. Simian–human immunodeﬁciency viruses
expressing subtype C Vpu proteins with the Y35A (SHIVSCVpuY35A), the
L39G (SHIVSCVpuL39G), and YL35,39AG (SHIVSCVpuYL35,39AG) amino acid
substitutions were constructed as previously described (McCormick-
Davis et al., 2000b; Stephens et al., 2002; Singh et al., 2003; Hout et al.,
2005; 2006; Hill et al., 2008). Stocks were prepared, titrated in C8166
cells and frozen at −86 °C until used.
Pulse-chase analysis of viral proteins
To analyze the viral proteins synthesized and released from cells,
C8166 cells were inoculated with 104 TCID50 of either SHIVSCVpuY35A,
SHIVSCVpuL39G, SHIVSCVpuYL35,39AGor SHIVSCVpu. At 7dayspost-inoculation,
the medium was removed and infected cells were incubated in
methionine/cysteine-free Dulbecco's modiﬁed Eagle's medium (DMEM)
for 2 h. The cells were then radiolabeled for 30 minwith 1mCi per ml of
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and the radiolabel chased for variousperiodsof time inDMEMcontaining
100× unlabeled methionine/cysteine. SHIV proteins were immunopreci-
pitated from the cell culture medium and infected cell lysates using
plasma pooled from several rhesus monkeys infected previously with
non-pathogenic SHIV-4. Brieﬂy, the cell culture medium was clariﬁed
(16,000 ×g) for 2min. The supernatantwas transferred andmade1×with
respect to cell lysis buffer (50 mM Tris–HCl, pH 7.5; 50 mM NaCl; 0.5%
deoxycholate; 0.2% SDS; 10 mM EDTA) and SHIV proteins were
immunoprecipitatedwith 10 μl of a pooled serum. For immunoprecipita-
tion of cell associated SHIV proteins, cell lysates were prepared as
previously described (Stephens et al., 1995; McCormick-Davis et al.,
2000b; Hout et al., 2005) prior to incubation with antiserum. Lysates
were centrifuged in amicrofuge to remove nuclei prior to the addition of
antibody. Cell lysates and culturemediumwere incubatedwith antibody
for 16 h at 4 °C. All immunoprecipitates were collected on protein A
Sepharose, the beads washed three times with RIPA buffer, and the
samples resuspended in sample reducing buffer. Samples were boiled
and the SHIV speciﬁc proteins analyzed by SDS-PAGE. Proteinswere then
visualized by standard autoradiographic techniques.
Assays for assessing the cell surface Vpu expression
To determine if Vpu proteins were expressed on the plasma mem-
brane, 293 cells were transfected with 4.75 μg of plasmid DNA
expressing EGFP, VpuSCEGFP1, VpuSCEGFPY35A, VpuSCEGFPL39G, or
VpuSCEGFPYL35,39AG. At 48 h post-transfection, cells were incubated
in methionine/cysteine-free media for 2 h and then labeled with
200 μCi of 35S for 1 h. Cells were washed three times in ice-cold 1× PBS
and the surface of cells labeled with EZ-Link Sulfo-NHS-LC-Biotin
(Pierce) at a concentration of 10 mg per ml for 1 h on ice. Cells were
then washed three times in 1× PBS containing 100 mM glycine. The
cells were lysed in 1 ml of 1× RIPA buffer and nuclei were removed by
centrifugation at 14,000 rpm for 15 min. Cell lysates were incubated
overnight at 4 °C with a rabbit polyclonal anti-EGFP antibody and
protein A Sepharose beads. Lysate immunoprecipitates were washed
three times in 1× RIPA, resuspended in 100 μl of 2× sample reducing
buffer, and boiled for 5 min. Proteins were separated on a 10% SDS-
PAGE gel and densitometry was used to quantify the total amount of
VpuEGFP fusion expressed in each sample. Equal amounts of fusion
proteinswere then separated on a 10% SDS-PAGE gel, the proteinswere
transferred to nitrocellulose and a Western blot was used to detect
biotin-labeled proteins. Biotin-labeled proteins were detected using a
Vectastain-ABC-AmP chemiluminescent detection kit (Vector Labora-
tories). A BioRad chemiluminescent imager was used to quantify the
total amount of biotin-labeled VpuEGFP in each sample. The experi-
ments were conducted in triplicate and a Student's t-test was used to
determine statistical signiﬁcance with pb0.05 considered signiﬁcant.
Assays for assessing cell surface expression of CD4
For analysis of cell surface CD4 expression in the presence of
various ﬂuorescent proteins, HeLa CD4+ cells were seeded into six well
plates 1 day in advance, such that 24 h later they would be 70–80%
conﬂuent. Cells were transfected with plasmids expressing EGFP or
various Vpu proteins fused to EGFP. Cultures were monitored for 48 h,
cells removed from the six well plate using Ca++ /Mg++-free PBS
containing 10mMEDTA and stainedwith PE-Cy5 conjugated anti-CD4
(BD Bioscience). Cells were analyzed using an LSR II ﬂow cytometer,
determining mean ﬂuorescence intensity (MFI) of PE-Cy5 for
transfected (EGFP positive) and untransfected (EGFP negative) cells
within the same well. An MFI ratio was calculated for each sample
with EGFP control normalized to 1.0. Normalized ratios from at least
ﬁve separate experiments were averaged and the standard deviation
calculated. All groups were compared using Student's t-test (unpaired,
pb0.05 signiﬁcant).p27 growth curve assays
Standard p27 assays (Zeptometrix Incorporated, SIV core antigen
kit) were used to assess release of viral particles from cells infected
with SHIVSCVpu, SHIVSCVpuY35A, SHIVSCVpuL39G or SHIVSCVpuYL35,39AG.
Cultures of 106 C8166 cells were inoculated with 10 ng of p27
(determine by commercial p27 antigen kits) for 4 h. At the end of 4 h,
the cells were centrifuged at 400×g for 10 min and the pellet washed
with 10 ml of medium. This was repeated two additional times. The
cells were resuspended in RPMI-1640 supplementedwith 10% FBS and
antibiotics and this was considered the 0 time point of the assay.
Cultures were incubated at 37 °C and aliquots of the culture were
removed at 0,1, 3, 5, 7, and 9 dayswith freshmedia added to cultures at
days 3 and 6. The culture medium was separated from the cells by
centrifugation and assayed for p27 according to the manufacturer's
instructions.
Electron microscopy
To determine the site(s) of intracellular maturation, infected cells
were examined by transmission electron microscopy. Cultures of 106
C8166 cells were inoculated with 10 ng of SHIVSCVpu, SHIVSCVpuY35A,
SHIVSCVpuL39G or SHIVSCVpuYL35,39AG. Cells were incubated for 5 days at
which time cells were pelleted at 400 ×g for 10min. Cells werewashed
three times with 10 ml of phosphate buffered saline (pH 7.4) and ﬁxed
in 2% glutaraldehyde overnight at 4 °C. Cells were post-ﬁxed in 2%
osmium tetroxide (OsO4) for 1 h. The cells were washed twice with
water and dehydrated through a series of alcohols (30–100%) followed
by embedding in Embed 812 resin. Thin sections were cut at 80 A,
stained with uranyl acetate and lead citrate and examined under a
JEOL 100CXII transmission electron microscope. The number of virus
particles associated with 50 infected cells (either at the surface or
within the cell) were enumerated and data analyzed by planned
comparisons using unpaired t-test.
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